Insomnia

Lancet

Volumn 364, Issue 9449, 2004, Pages 1959-1973

  Sateia, Michael J ^a   Nowell, Peter D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC AGENT;

BEHAVIOR THERAPY; CIRCADIAN RHYTHM; CONFERENCE PAPER; DRUG INDICATION; DRUG USE; HABIT; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HUMAN; INSOMNIA; MENTAL DISEASE; NURSE; PERIODIC LIMB MOVEMENT; PRIORITY JOURNAL; PSYCHOLOGIST; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 9644268319     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17480-1     Document Type: Conference Paper

References (174)

1. Morin C. Insomnia: psychological assessment and management. 1993;The Guilford Press, New York
2. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep. 23:2000;243-308
3. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry. 171:1997;382-388
4. Chevalier H, Los F, Boichut D, et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol. 13:(4 Suppl 1):1999;S21-S24
5. Hohagen F, Rink K, Käppler C, et al. Prevalence and treatment of insomnia in general practice: a longitudinal study. Eur Arch Psychiatry Clin Neurosci. 242:1993;329-336
6. Hatoum HT, Kania CM, Kong SX, Wong JM, Mendelson WB. Prevalence of insomnia: a survey of the enrollees at five managed care organizations. Am J Manag Care. 4:1998;79-86
7. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 154:1997;1417-1423
8. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES project. J Am Geriatr Soc. 44:1996;778-784
9. Ohayon MM, Zulley J, Guilleminault C, Smirne S, Priest RG. How age and daytime activities are related to insomnia in the general population: consequences for older people. J Am Geriatr Soc. 49:2001;360-366
10. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep. 25:2002;625-629
11. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. Sleep. 14:1991;392-398
12. Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci. 251:2001;49-56
13. Ohayon M. Epidemiological study on insomnia in the general population. Sleep. 19:(suppl 3):1996;S7-15
14. Mellinger G, Balter M, Uhlenhuth E. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 42:1985;25-232
15. Barbar SI, Enright PL, Boyle P, et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J Gerontology Series A Biol Sci Med Sci. 55:2000;M406-M411
16. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 22:(suppl 2):1999;S366-S372
17. Roberts RE, Shema SJ, Kaplan GA. Prospective data on sleep complaints and associated risk factors in an older cohort. Psychosom Med. 61:1999;188-196
18. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 158:1998;1099-1107
19. Klink M, Quan S, Kaltenborn W, Lobowitz M. Risk factors associated with complaints of insomnia in a general adult population. Arch Intern Med. 152:1992;1634-1637
20. Gislason T, Reymisdötter H, Kritbjarnarson H, Benediktsdötter B. Sleep habits and sleep disturbances among the elderly: an epidemiological survey. J Intern Med. 234:1993;31-39
21. Janson C, Lindberg E, Gislason T, Elmasry A, Boman G. Insomnia in men: a 10-year prospective population based study. Sleep. 24:2001;425-430
22. Jensen E, Dehlin O, Hagberg B, Samuelsson G, Svensson T. Insomnia in an 80-year-old population: relationship to medical, psychological and social factors. J Sleep Res. 7:1998;183-189
23. Gislason T, Reymisdötter H, Kritbjarnarson H, Benediktsdötter B. Sleep habits and sleep disturbances among the elderly: an epidemiological survey. J Intern Med. 234:1993;31-39
24. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 39:1996;411-418
25. Ford D, Kamerow D. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 262:1989;1479-1484
26. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 19:1997;245-250
27. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep. 22:(suppl 2):1999;S379-S385
28. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia: an overview. Pharmacoeconomics. 10:(suppl 1):1996;1-14
29. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 22:(suppl 2):1999;S386-S393
30. Stoller MK. Economic effects of insomnia. Clin Ther. 16:1994;873-897
31. Gallup Organization. Sleep in America. 1995;Gallup Organization, Princeton, NJ
32. Rosen R, Zozula R. Education and training in the field of sleep medicine. Curr Opin Pulm Med. 6:2000;512-518
33. Babkoff H, Weller A, Lavidor M. A comparison of prospective and retrospective assessments of sleep. J Clin Epidemiol. 49:1996;455-460
34. Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28:1989;193-213
35. Morin C, Stone J, Trinkle D, Mercer J, Remsberg S. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging. 8:1993;463-467
36. Douglass AB, Bornstein R, Nino-Murcia G, et al. The Sleep Disorders Questionnaire: I - creation and multivariate structure of SDQ. Sleep. 17:1994;160-167
37. Lacks P, Rotert M. Knowledge and practice of sleep hygiene techniques in insomniacs and poor sleepers. Behav Res Ther. 24:1986;365-368
38. Regestein Q, Dambrosia J, Hallett M, Murawski B, Paine M. Daytime alertness in patients with primary insomnia. Am J Psychiatry. 150:1993;1529-1534
39. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 14:1991;540-545
40. Chesson AL Jr, Ferber RA, Fry JM, et al. The indications for polysomnography and related procedures. Sleep. 20:1997;423-487
41. Littner M, Kushsida C, Anderson WM, et al. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 26:2003;337-341
42. Zammit G. Subjective ratings of the characteristics and sequelae of good and poor sleep in normals. J Clin Psychol. 44:1988;123-130
43. Stepanski E, Koshorek G, Zorick F, Glinn M, Roehrs T, Roth T. Characteristics of individuals who do or do not seek treatment for chronic insomnia. Psychosomatics. 30:1989;421-427
44. Bonnet MH, Arand DL. The consequences of a week of insomnia. Sleep. 19:1996;453-461
45. Means MK, Lichstein KL, Epperson MT, Johnson CT. Relaxation therapy for insomnia: nighttime and day time effects. Behav Res Ther. 38:2000;665-678
46. Stepanski E, Zorick F, Roehrs T, Young D, Roth T. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep. 11:1988;54-60
47. Sugerman J, Stern J, Walsh J. Daytime alertness in subjective and objective insomnia: some preliminary findings. Biol Psychiatry. 20:1985;741-750
48. Bonnet MH, Arand DL. Physiological activation in patients with Sleep State Misperception. Psychosom Med. 59:1997;533-540
49. Vgontzas AN, Kales A, Bixler EO, Manfredi RL, Vela-Bueno A. Usefulness of polysomnographic studies in the differential diagnosis of insomnia. Int J Neurosci. 82:1995;47-60
50. Kales A, Caldwell A, Soldatos C, Bixler E, Kales J. Biopsychobehavioral correlates of insomnia: II - pattern specificity and consistency with the MMPI. Psychosom Med. 45:1983;341-356
51. Hauri P, Fischer J. Persistent psychophysiological (learned) insomnia. Sleep. 9:1986;38-53
52. Kalogjera-Sackellares D, Cartwright RD. Comparison of MMPI profiles in medically and psychologically based insomnias. Psychiatry Res. 70:1997;49-56
53. Freedman R, Sattler H. Physiological and psychological factors in sleep-onset insomnia. J Abnorm Psychol. 91:1982;380-389
54. Vgontzas AN, Tsigos C, Bixler EO, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res. 45:1998;21-31
55. Perlis ML, Smith MT, Andrews PJ, Orff H, Giles DE. Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep. 24:2001;110-117
56. Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep. 25:2002;630-640
57. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 10:1987;541-553
58. Harvey AG. A cognitive model of insomnia. Behav Res Ther. 40:2002;869-893
59. Espie CA. Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu Rev Psychol. 53:2002;215-243
60. Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK. Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res. 6:1997;179-188
61. Buysse DJ, Reynolds CF, 3rd, Kupfer DJ, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994; 17: 630-37.
62. Sack R. Shift work and jet lag. Lee-Chiong TL, Sateia MJ, Carskadon MA. Sleep Medicine. 2002;255-263 Hanley and Belfus, Philadelphia
63. Regestein QR, Monk TH. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry. 152:1995;602-608
64. Lockley SW, Skene DJ, Butler LJ, Arendt J. Sleep and activity rhythms are related to circadian phase in the blind. Sleep. 22:1999;616-623
65. Leger D, Guilleminault C, Defrance R, Domont A, Paillard M. Prevalence of sleep/wake disorders in persons with blindness. Clin Sci. 97:1999;193-199
66. Skene DJ, Lockley SW, Arendt J. Use of melatonin in the treatment of phase shift and sleep disorders. Adv Exp Med Biol. 467:1999;79-84
67. Skene DJ, Lockley SW, Arendt J. Melatonin in circadian sleep disorders in the blind. Biol Signals Recept. 8:1999;90-95
68. Regestein QR, Pavlova M. Treatment of delayed sleep phase syndrome. Gen Hosp Psychiatry. 17:1995;335-345
69. Terman M, Terman JS. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 60:1999;799-808
70. Cardinali DP, Brusco LI, Lloret SP, Furio AM. Melatonin in sleep disorders and jet-lag. Neuroendocrinol Lett. 23:(suppl 1):2002;9-13
71. Eastman CI, Boulos Z, Terman M, Campbell SS, Dijk DJ, Lewy AJ. Light treatment for sleep disorders: consensus report: VI - shift work. J Biol Rhythms. 10:1995;157-164
72. Wilson KG, Eriksson MY, D'Eon JL, Mikail SF, Emery PC. Major depression and insomnia in chronic pain. Clin J Pain. 18:2002;77-83
73. Smith MT, Perlis ML, Carmody TP, Smith MS, Giles DE. Presleep cognitions in patients with insomnia secondary to chronic pain. J Behav Med. 24:2001;93-114
74. Currie SR, Wilson KG, Pontefract AJ, deLaplante L. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol. 68:2000;407-416
75. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 19:2001;895-908
76. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med. 54:2002;1309-1321
77. Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 19:1998;260-265
78. Cohen FL, Ferrans CE, Vizgirda V, Kunkle V, Cloninger L. Sleep in men and women infected with human immunodeficiency virus. Holist Nurs Pract. 10:1996;33-43
79. Douglas NJ. Sleep in patients with chronic obstructive pulmonary disease. Clin Chest Med. 19:1998;115-125
80. McNicholas WT. Impact of sleep in COPD. Chest 2000; 117 (2 suppl): 48S-53S.
81. George CF. Perspectives on the management of insomnia in patients with chronic respiratory disorders. Sleep. 23:(suppl 1):2000;S31-S35
82. Moldofsky H. Rheumatologic disorders and sleep. Lee-Chiong TL, Sateia MJ, Carskadon MA. Sleep Medicine. 2002;471-476 Hanley and Belfus, Philadelphia
83. Prinz PN PJ, McCurry S. Sleep in the dementing disorders. Lee-Chiong TL, Sateia MJ, Carskadon MA. Sleep Medicine. 2002;497-508 Hanley and Belfus, Philadelphia
84. Lugaresi I, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med. 315:1986;997-1003
85. Lugaresi A, Baruzzi A, Cacciari E, et al. Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration. Clin Endocrinol. 26:1987;573-580
86. Medori R, Tritschler HJ, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 326:1992;444-449
87. Krakow B, Melendrez D, Ferreira E, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest. 120:2001;1923-1929
88. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep. 19:1996;219-223
89. Karadeniz D, Ondze B, Besset A, Billiard M. Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients? Eur J Neurol. 7:2000;331-336
90. Anonymous. Restless legs syndrome: detection and management in primary care. Am Fam Physician. 62:2000;108-114
91. Trenkwalder C. Restless legs syndrome and periodic limb movements. Adv Neurol. 89:2002;145-151
92. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol. 7:(suppl 1):2000;27-31American Sleep Disorders Association
93. Jo X. International Classification of Sleep Disorders, Diagnostic and Coding Manual. 1990;American Sleep Disorders Association, Rochester, MN
94. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 281:1999;991-999
95. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 151:1994;1172-1180
96. Murtagh DR, Greenwood KM. Identifying effective psychological interventions for insomnia: a meta-analysis. J Consult Clin Psychol. 63:1995;79-89
97. Bootzin RR, Nicassion PM. Behavioral treatments for insomnia. Hersen M, Eissler R, Miller P. Progress in Behavior Modification. 1978;1-45 Academic Press, New York, NY
98. Spielman A, Saskin P, Thorpy M. Treatment of chronic insomnia by restriction of time in bed. Sleep. 10:1987;45-56
99. Chesson AL Jr, Anderson WM, Littner M, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia: an American Academy of Sleep Medicine report. Sleep. 22:1999;1128-1133
100. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia: an American Academy of Sleep Medicine review. Sleep. 22:1999;1134-1156
101. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 285:2001;1856-1864
102. Backhaus J, Hohagen F, Voderholzer U, Riemann D. Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci. 251:2001;35-41
103. Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 39:2001;45-60
104. Lacks P, Bertelson AD, Sugerman J, Kunkel J. The treatment of sleep-maintenance insomnia with stimulus-control techniques. Behav Res Ther. 21:1983;291-295
105. Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+ (Cochrane Review). In: The Cochrane Library, issue 2. Oxford: Update Software, 2002.
106. Montgomery P, Dennis J. A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev. 8:2004;47-62
107. Pallesen S, Nordhus IH, Kvale G, et al. Behavioral treatment of insomnia in older adults: an open clinical trial comparing two interventions. Behav Res Ther. 41:2003;31-48
108. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 63:1995;79-89
109. Verbeek I, Schreuder K, Declerck G. Evaluation of short-term nonpharmacological treatment of insomnia in a clinical setting. J Psychosom Res. 47:1999;369-383
110. Espie CA, Inglis SJ, Harvey L. Predicting clinically significant response to cognitive behavior therapy for chronic insomnia in general medical practice: analysis of outcome data at 12 months posttreatment. J Consult Clin Psychol. 69:2001;58-66
111. Perlis ML, Sharpe M, Smith MT, Greenblatt D, Giles D. Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidity. J Behav Med. 24:2001;281-296
112. Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging. 15:2000;232-240
113. Davidson JR, Waisberg JL, Brundage MD, MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology. 10:2001;389-397
114. Morgan K, Dixon S, Mathers N, Thompson JJ, Tomeny M. Psychological treatment for insomnia in the regulation of long-term drug use. Health Technol Assess. 8:2004;1-68
115. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 278:1997;2170-2177
116. Elie R, Ruther E, Farr I, Emilien G, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry. 60:1999;536-544
117. Hedner J, Yaeche R, Emilien G, Farr I, Salinas E. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. Int J Geriatr Psychiatry. 15:2000;704-712
118. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 162:2000;225-233
119. Roehrs T, Roth T. Hypnotics: efficacy and adverse effects. Kryger MH, Roth T, Dement WC. Principles and Practice of Sleep Medicine. 2000;414-418 W B Saunders, Philadelphia
120. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia: report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry. 59:2002;131-136
121. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc. 48:2000;682-685
122. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. Psychopharmacology. 108:1992;67-71
123. Roth T, Roehrs TA. A review of the safety profiles of benzodiazepine hypnotics. J Clin Psychiatry. 52(suppl):1991;38-41
124. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep. 22:1999;371-375
125. McCall WV. Pharmacologic treatment of insomnia. Lee-Chiong TL, Sateia MJ, Carskadon MA. Sleep Medicine. 2002;169-176 Hanley and Belfus, Philadelphia
126. Riemann DV. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry. 35:2002;165-174
127. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 151:1994;1069-1072
128. Hohagen F, Montero RF, Weiss E, et al. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci. 244:1994;65-72
129. Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry. 62:2001;453-463
130. Nowell PD, Reynolds CF, Buysse DJ, Dew MA, Kupfer DJ. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry. 60:1999;89-95
131. Chesson A Jr, Hartse K, Anderson WM, et al. Practice parameters for the evaluation of chronic insomnia: an American Academy of Sleep Medicine report. Sleep. 23:2000;237-241
132. Task Force of the Collegium Internationale Neuro-Psychopharmacologicum (CINP). Impact of neuropharmacology in the 1990s: treatment strategies for anxiety disorders and insomnia. Eur Neuropsychopharmacol. 2:1992;167-169
133. US Department of Health Education and Welfare. Guidelines for the Clinical Evaluation of Hypnotic Drugs. US Department of Health Education and Welfare, 1977.
134. Borbely AA, Akerstedt T, Benoit O, Holsboer F, Oswald I. Hypnotics and sleep physiology: a consensus report. Eur Arch Psychiatry Clin Neurosci. 241:1991;13-21
135. National Heart Lung and Blood Institute Working Group on Insomnia. Insomnia: assessment and management in primary care. Am Fam Physician. 59:1999;3029-3038
136. National Institute of Mental Health. Consensus Conference Report: drugs and insomnia: the use of medication to promote sleep. JAMA. 251:1984;2410-2414
137. Nowell PD, Buysse DJ, Morin CM, Reynolds CF, Kupfer DJ. Effective treatments for selected sleep disorders. Nathan PE, Gorman JM. A Guide to Treatments That Work. 2002;593-609 Oxford University Press, New York, NY
138. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med. 336:1997;341-346
139. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1994;American Psychiatric Association, Washington DC
140. WHO. International Classification of Diseases. 9th edn:1978;World Health Organization, Geneva
141. Nowell PD, Hall M, Buysse DJ, Reynolds CF. Psychometric and Psychiatric Evaluation. Kryger MH, Roth T, Dement WC. Principles and Practice of Sleep Medicine. 2000;1290-1294 W B Saunders, Philadelphia
142. Nowell PD, Buysse DJ, Reynolds CF III, et al. Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders. Am J Psychiatry. 154:1997;1412-1416
143. Buysse DJ, Reynolds CF 3rd, Kupfer DJ, et al. Effects of diagnosis on treatment recommendations in chronic insomnia: a report from the APA/NIMH DSM-IV field trial. Sleep 1997; 20: 542-52.
144. Ohayon MM, Caulet M. Insomnia and psychotropic drug consumption. Prog Neuropsychopharmacol Biol Psychiatry. 19:1995;421-431
145. Schlich D, Heritier C, Coquelin JP, Attali P, Kryrein HJ. Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients. J Int Med Res. 19:1991;271-279
146. Kummer J, Guendel L, Linden J, et al. Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia. J Int Med Res. 21:1993;171-184
147. Mendelson WB. Long-term follow-up of chronic insomnia. Sleep. 18:1995;698-701
148. Monti JM, Monti D, Estevez F, Giusti M. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. Int Clin Psychopharmacol. 11:1996;255-263
149. Maarek L, Cramer P, Attali P, Coquelin JP, Morselli PL. The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J Int Med Res. 20:1992;162-170
150. Krystal A, Walsh J, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 26:2003;793-799
151. Roth T, Krystal A, Walsh J, Roehrs T, Wessel T, Caron J. Twelve months of nightly eszopiclone treatment in patients with chronic insomnia: assessment of long-term efficacy and safety. Sleep. 27:2004;A260
152. Bunney WE Jr, Azarnoff DL, Brown BW Jr, et al. Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry. 56:1999;349-352
153. Monti JM, Boussard M, Olivera S, Labraga P, Alvarino F. The effect of midazolam on transient insomnia. Eur J Clin Pharmacol. 44:1993;525-527
154. Roth T, Roehrs T, Vogel G. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep. 18:1995;246-251
155. Lenhart SE, Buysse DJ. Treatment of insomnia in hospitalized patients. Ann Pharmacother. 35:2001;1449-1457
156. Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry. 60:1999;668-676
157. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 151:1994;1069-1072
158. Walsh J, Rosenberg R, Roth T, Lankford D, Jochelson P. Treatment of primary insomnia for five weeks with Indiplon-IR. Sleep. 27:2004;A259
159. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction. 98:2003;1371-1378
160. Cluydts R, Peeters K, de Bouyalsky I, Lavoisy J. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study. J Int Med Res. 26:1998;13-24
161. Hajak GB. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia: assessment of a novel intervention strategy in a primary care setting. Ann Clin Psychiatry. 14:2002;1-7
162. Hajak GC. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol. 17:2002;9-17
163. Bonnet MH, Arand DL. The use of lorazepam TID for chronic insomnia. Int Clin Psychopharmacol. 14:1999;81-89
164. Morin CM, Mimeault V, Gagne A. Nonpharmacological treatment of late-life insomnia. J Psychosom Res. 46:1999;103-116
165. Voderholzer U, Riemann D, Hornyak M, et al. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. Eur Arch Psychiatry Clin Neurosci. 251:2001;117-123
166. Roger M, Attali P, Coquelin JP. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther. 15:1993;127-136
167. Nakra BR, Gfeller JD, Hassan R. A double-blind comparison of the effects of temazepam and triazolam on residual, daytime performance in elderly insomniacs. Int Psychogeriatr. 4:1992;45-53
168. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep. 20:1997;908-915
169. Olde RM, Rigaud AS. Melatonin in elderly patients with insomnia: a systematic review. Z Gerontol Geriatr. 34:2001;491-497
170. Pasche B, Erman M, Hayduk R, et al. Effects of low energy emission therapy in chronic psychophysiological insomnia. Sleep. 19:1996;327-336
171. Herrera-Arellano AL. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia. Planta Med. 67:2001;695-699
172. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 159:2002;5-11
173. McClusky HY, Milby JB, Switzer PK, Williams V, Wooten V. Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry. 148:1991;121-126
174. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, Morin CM. Discontinuation of benzodiazepine treatment among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ. 169:2003;1015-1020